ArticleAnnals of clinical and translational neurology2022

An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy.

Jennifer M Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.